中山大学附属第三医院感染科副主任,主任医师,医学博士,硕士生导师。现任广东省医学会感染病学分会候任主任委员,中华预防医学会感染病防控分会常委兼秘书,中华医学会感染病学分会全国委员,中华医学会热带病与寄生虫病学会寄生虫病学组委员,中华医学会肝脏病学分会自身免疫性肝病协作组委员,中国研究型医院学会肝脏病学分会重症肝病学组委员,,广东省寄生虫病学会常务理事。
发表的部分SCI论文:
1.Lin BL, Xie DY, Xie SB, et al. Down-regulation of iASPP in human hepatocellular carcinoma cells inhibits cell proliferation and tumor growth,Neoplasma,2011,58(3),205-210
2.Lin BL, Pan Calvin Q, et al. Entecavir improves the outcome of acute-on- chronic liver failure due to the acute exacerbation of chronic hepatitis B. Hepatology International. 2013 June; 7(2):460-467
3.Chen JF, Wang KW, Lin BL(Corresponding author). Dexamethasone in outcome of patients with hepatitis B virus-related acute-on-chronic liver failure. Journal of Gastroenterol Hepatol. 2014 April;29(4):800-806
4.Lin BL, Chen JF, Qiu WH, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial. Hepatology. 2017 Jul;66(1):209-219.